Firms

Casdin Capital

casdincapital.com

Signal profile (Casdin Capital) Casdin Capital cb Casdin Capital is a fundamental research investment firm focused on the life sciences and healthcare industry. It manages a long-short equity fund and makes investments in early-stage to late-stage private investments. Casdin was launched in 2012 by founder and CIO Eli Casdin and as of October 2020 has approximately $2.2 billion in assets undermanagement. SHOW MORE Founded: 2012

Founded: 2012
Type: Venture capital

Funds0

No funds on record yet.

Team

No team members on record yet.

Co-investing

Investments

$97M2025-11-13	Beacon Biosignals	Anthony Philippakis, Hemant Taneja, GV, Innoviva, Nexus NeuroTech Ventures, Catalio Capital Management, Takeda, General Catalyst, Caitlin Donovan, Logos Capital, Casdin Capital, Indicator Ventures, Alumni Ventures, Synetro Group, Iaso Ventures
$27M2021-11-08	Beacon Biosignals	General Catalyst, Hemant Taneja, Andrew Beck, Gaurav Singal, Arif Nathoo, Casdin Capital
$99M2026-06-08	City Therapeutics	ARCH Venture Partners, Casdin Capital, Viking Global Investors, Fidelity Investments, Sofinnova Partners, Rock Springs Capital
$35M2025-09-04	Octave Bioscience	S32, The Blue Venture Fund, Casdin Capital, Northpond Ventures, Merck Global Health Innovation Fund, Section 32
$60M2024-01-03	Remix Therapeutics	ARCH Venture Partners, Casdin Capital, Atlas Venture, Alexandria Venture Investments, W.T.T. Investment Ltd., Surveyor Capital
$75M2024	nChroma	ARCH Venture Partners, Casdin Capital, Atlas Venture, Wellington Management, F-Prime Capital, Cormorant Asset Management
$115M2024	Maze Therapeutics	ARCH Venture Partners, Casdin Capital, Andreessen Horowitz, Logos Capital, GV, General Catalyst, Moore Strategic Ventures
$270M2023-04-26	Orbital Therapeutics	ARCH Venture Partners, Casdin Capital, Alexandria Venture Investments, Andreessen Horowitz, Moore Strategic Ventures, Newpath Partners, Vineeta Agarwala
$135M2023-03-01	Chroma Medicine	ARCH Venture Partners, Casdin Capital, Atlas Venture, DCVC, Wellington Management, Cormorant Asset Management, Osage University Partners
$8M2023-01-10	Nest Genomics	Y Combinator, Casdin Capital, DCVC, Samsung Next, B Capital, LionBird
$20M2022-03-18	Volta Labs	Khosla Ventures, Casdin Capital, Maverick Ventures, Illumina Ventures, E14 Fund
$75M2022-01-20	ONI	ARCH Venture Partners, Casdin Capital, S32, Axon Partners Group, The Vertical Group, Oxford Science Enterprises, Section 32
$156M2021-09-30	Formation Bio	S32, Casdin Capital, Dragoneer Investment Group, Thrive Capital, Sound Ventures, Spark Capital, Sequoia, Felicis, Section 32
$265M2021-08-04	Sonoma Biotherapeutics	ARCH Venture Partners, 8VC, Casdin Capital, Mirae Asset, Lifeforce Capital, Vertex Ventures HC, Osage University Partners
$200M2021-07-13	Prime Medicine, Inc.	ARCH Venture Partners, F-Prime Capital, GV, Newpath Partners, Casdin Capital, Cormorant Asset Management, Moore Strategic Ventures, PSP Investments, Redmile Group, Samsara BioCapital, T. Rowe Price Associates
$100M2021-04-15	C2i Genomics	S32, Casdin Capital, Gobi Partners, Duquesne Family Office, NFX, Silver Lake, Section 32
$117M2021-03-04	Amunix Pharmaceuticals	Bain Capital, Venrock, Casdin Capital, Franklin Templeton, Viking Global Investors, Longitude Capital
$117M2021-03-04	Amunix	Bain Capital, Venrock, Casdin Capital, Franklin Templeton, Viking Global Investors, Longitude Capital
$1.8B2021	EQRx	Bain Capital, Casdin Capital, Franklin Templeton, Andreessen Horowitz, BVF Partners L.P., Mubadala Investment Company
$20M2021	Multiply Labs	Founders Fund, Casdin Capital, Fifty Years, Y Combinator, Lux Capital, Pathfinder
$35M2020-02-05	Vineti	S32, Casdin Capital, Threshold Ventures, Lifeforce Capital, Kite, a Gilead Company, Hive Ventures, Section 32
$76M2020	Nautilus Biotechnology	Bain Capital, Casdin Capital, Franklin Templeton, Defy, Andreessen Horowitz, OrbiMed
$82M2019-04-30	Vividion Therapeutics	ARCH Venture Partners, Casdin Capital, Mirae Asset, Alexandria Venture Investments, Mubadala Ventures, Celgene
$—2019-04-29	908 Devices	ARCH Venture Partners, Casdin Capital, Hercules Capital, Inc., Tao Capital Partners, Northpond Ventures, Razor's Edge Ventures
$76M2017-11-29	Codiak Biosciences	ARCH Venture Partners, Casdin Capital, Alexandria Venture Investments, Alaska Permanent Fund Corporation, BECO Capital, Ona Capital
$250M2017-09-12	23andMe	Sequoia, Casdin Capital, Altimeter Capital Management, LP, Fidelity Investments, Euclidean Capital
$175MUnknown date	Asimov	Y Combinator, Casdin Capital, Horizons Ventures
$93MUnknown date	Character Biosciences	S32, Innovation Endeavors, Casdin Capital, Catalio Capital Management, aMoon, Sanofi Ventures
$—Unknown date	Prime Medicine, Inc.	ARCH Venture Partners, Casdin Capital, F-Prime Capital, T. Rowe Price, Cormorant Asset Management, Public Sector Pension Investment Board
$82MUnknown date	Vividion	ARCH Venture Partners, Casdin Capital, Mirae Asset, Alexandria Venture Investments, Mubadala Ventures, Celgene
$72MUnknown date	Rome	ARCH Venture Partners, Casdin Capital, Mirae Asset, Alexandria Venture Investments, Y Combinator, Sanofi Ventures, Mass General Brigham Ventures
$—Unknown date	Earli	Khosla Ventures, Perceptive Advisors, Sands Capital, Casdin Capital